STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
71
13F, latest reported quarter
Conversions, 180 days
2
Codes C/M, not in net · $62.9K priced
What the filings say about GEVO
Insiders, 180 days
-$1.6M net sold
2 buyers · 7 sellers · 14% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$552.3K
10 notices
Gevo insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, Gevo, Inc. insiders sold a net $1.6M of stock across 143 Form 4 purchases and sales, with 2 insiders buying. Source: SEC Form 4 filings, as of 2026-10-28.
14 earlier Form 4 trades (code P or S) here by this insider (14 sales), the last on Aug 6, 2026.
The trade is 0.1% of the 3,320,455 shares held after it.
3 other insiders sold within 30 days.
71 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Gruber Patrick R. sold about $5.7K of GEVO under a 10b5-1 plan on Sep 3, 2026; 3 other insiders sold within 30 days and 71 funds added in the latest 13F quarter.
15 earlier Form 4 trades (code P or S) here by this insider (15 sales), the last on Aug 6, 2026.
The trade is 0.2% of the 684,817 shares held after it.
3 other insiders sold within 30 days.
71 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief of Staff Bowron Kimberly T sold about $2.1K of GEVO under a 10b5-1 plan on Sep 3, 2026; 3 other insiders sold within 30 days and 71 funds added in the latest 13F quarter.
16 earlier Form 4 trades (code P or S) here by this insider (16 sales), the last on Aug 6, 2026.
The trade is 0.1% of the 1,500,789 shares held after it.
3 other insiders sold within 30 days.
71 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CEO Bloom Paul D sold about $2.6K of GEVO under a 10b5-1 plan on Sep 3, 2026; 3 other insiders sold within 30 days and 71 funds added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 41.7% of the 120,000 shares held after it.
1 other insider bought within 30 days.
71 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Barber James J bought about $77.0K of GEVO on Aug 21, 2026, the largest insider purchase at the company since 2022; 1 other insider bought within 30 days and 71 funds added in the latest 13F quarter.
First Form 4 purchase or sale (code P or S) here by this insider on our record.
The trade is 4.5% of the 276,788 shares held after it.
1 other insider bought within 30 days.
71 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Legal & Emrg Biz Officer Kettner David Michael bought about $19.4K of GEVO on Aug 21, 2026, the largest insider purchase at the company since 2022; 1 other insider bought within 30 days and 71 funds added in the latest 13F quarter.
143 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $1.6M sold by insiders over 180 days, 71 funds added last quarter, $552.3K in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$177.5M
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM GEVO
FY Dec 2025
$160.6M
FY Dec 2024
$16.9M
FY Dec 2023
$17.2M
FY Dec 2022
$1.2M
FY Dec 2021
$711.0K
Jun 2026
$46.5M
Mar 2026
$42.9M
Dec 2025
$45.3M
Sep 2025
$42.7M
Jun 2025
$43.4M
Mar 2025
$29.1M
Dec 2024
$5.7M
Sep 2024
$2.0M
At each fiscal year end
Single quarter
Net margin, TTM
-119.9%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM GEVO
FY Dec 2025
-21.1%
FY Dec 2024
-464.9%
FY Dec 2023
-385.0%
FY Dec 2022
-8,341%
FY Dec 2021
n/a
Jun 2026
-380.5%
Mar 2026
-50.5%
Dec 2025
-13.9%
Sep 2025
-18.6%
Jun 2025
+4.9%
Mar 2025
-74.6%
Dec 2024
-308.9%
Sep 2024
-1,077%
At each fiscal year end
Single quarter
Free cash flow, TTM
-$56.7M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM GEVO
FY Dec 2025
-$43.5M
FY Dec 2024
-$108.5M
FY Dec 2023
-$108.2M
FY Dec 2022
-$128.4M
FY Dec 2021
n/a
Jun 2026
-$20.8M
Mar 2026
-$30.0M
Dec 2025
$8.7M
Sep 2025
-$14.6M
Jun 2025
-$7.8M
Mar 2025
-$29.9M
Dec 2024
-$33.5M
Sep 2024
-$20.8M
At each fiscal year end
Single quarter
Debt to equity
0.61x
long-term 2026-06-30 plus current 2026-06-30; equity 2026-06-30
Debt to equity GEVO
FY Dec 2025
0.35x
FY Dec 2024
0.14x
FY Dec 2023
0.12x
FY Dec 2022
0.11x
FY Dec 2021
0.12x
Jun 2026
0.61x
Mar 2026
0.37x
Dec 2025
0.35x
Sep 2025
0.35x
Jun 2025
0.35x
Mar 2025
0.36x
Dec 2024
0.14x
Sep 2024
0.13x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
-0.10x
TTM operating cash flow over long-term 2026-06-30 plus current 2026-06-30
Cash flow to debt GEVO
FY Dec 2025
-0.08x
FY Dec 2024
-0.85x
FY Dec 2023
-0.79x
FY Dec 2022
-0.66x
FY Dec 2021
-0.72x
Jun 2026
-0.10x
Mar 2026
-0.06x
Dec 2025
-0.08x
Sep 2025
-0.32x
Jun 2025
-0.34x
Mar 2025
-0.39x
Dec 2024
-0.85x
Sep 2024
-1.06x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
-57.0%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity GEVO
FY Dec 2025
-7.1%
FY Dec 2024
-15.0%
FY Dec 2023
-11.4%
FY Dec 2022
-17.0%
FY Dec 2021
-17.1%
Jun 2026
-57.0%
Mar 2026
-7.4%
Dec 2025
-7.1%
Sep 2025
-9.3%
Jun 2025
-11.7%
Mar 2025
-16.1%
Dec 2024
-15.0%
Sep 2024
-14.8%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
-35.2%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets GEVO
FY Dec 2025
-5.2%
FY Dec 2024
-12.7%
FY Dec 2023
-9.8%
FY Dec 2022
-14.6%
FY Dec 2021
-14.8%
Jun 2026
-35.2%
Mar 2026
-4.9%
Dec 2025
-5.2%
Sep 2025
-7.1%
Jun 2025
-8.7%
Mar 2025
-12.1%
Dec 2024
-12.7%
Sep 2024
-12.7%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
tax provision or pre-tax income not filed for the four quarters
Return on invested capital GEVO
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
-33.2%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed GEVO
FY Dec 2025
-3.4%
FY Dec 2024
-16.2%
FY Dec 2023
-13.3%
FY Dec 2022
-15.9%
FY Dec 2021
-15.8%
Jun 2026
-33.2%
Mar 2026
-0.8%
Dec 2025
-3.4%
Sep 2025
-6.4%
Jun 2025
-9.4%
Mar 2025
-13.7%
Dec 2024
-16.2%
Sep 2024
-16.4%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
P/E, trailing GEVO
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$390.9M
market value at close 2026-10-26 on 2026-08-05 shares, plus long-term 2026-06-30 plus current 2026-06-30, minus cash 2026-06-30
Enterprise value GEVO
FY Dec 2025
$568.2M
FY Dec 2024
$378.1M
FY Dec 2023
$48.5M
FY Dec 2022
$281.1M
FY Dec 2021
$890.2M
Jun 2026
$474.2M
Mar 2026
$750.7M
Dec 2025
$568.2M
Sep 2025
$565.9M
Jun 2025
$426.5M
Mar 2025
$379.7M
Dec 2024
$378.1M
Sep 2024
$234.1M
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
-20.1%
TTM free cash flow over market value at close 2026-10-26
FCF yield GEVO
FY Dec 2025
-9.0%
FY Dec 2024
-21.7%
FY Dec 2023
-38.8%
FY Dec 2022
-28.5%
FY Dec 2021
n/a
Jun 2026
-15.5%
Mar 2026
-6.6%
Dec 2025
-9.0%
Sep 2025
-18.1%
Jun 2025
-29.1%
Mar 2025
-37.7%
Dec 2024
-21.7%
Sep 2024
-25.8%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
PEG, trailing GEVO
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
GEVO ranks highest on growth (99th percentile) and risk and compliance (68th), and lowest on profitability (10th), among Materials peers.
Profitability
10
Inputs
Return on equity-57.0% · 11 pct, sector of 100
Return on assets-35.2% · 13 pct, sector of 120
Return on invested capitaltax provision or pre-tax income not filed for the four quarters
Return on capital employed-33.2% · 6 pct, sector of 96
Financial health
38
Inputs
Debt to equity0.61x · 55 pct, sector of 104
Cash flow to debt-0.10x · 21 pct, sector of 103
Growth
99
Inputs
Revenue growth, YoY+849.3% · 99 pct, sector of 128
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
55
Inputs
Net Form 4 buying (codes P and S), 180d-$1.6M · 28 pct, sector of 80
Insider buyers, 180d2 · 82 pct, sector of 80
Institutional and government
53
Inputs
Funds adding, latest quarter71 · 32 pct, sector of 118
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quarters$1.1M · 74 pct, sector of 40
Risk and compliance
68
Inputs
Short interest, % of float+9.7% · 20 pct, sector of 143
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5y0.00 per $1B · 100 pct, sector of 103
New text in Risk Factors, latest 10-K+4.7% · 85 pct, sector of 111
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
GEVO filings, in plain words
Are Gevo insiders buying or selling GEVO?
In the 180 days to 2026-10-28, Gevo insiders were net sellers, a net $1.6M: $96.4K of purchases and $1.7M of sales reported on Form 4, by 2 buyers and 7 sellers.
Are there planned insider sales of GEVO?
Yes. 10 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-28, covering $552.3K of stock; the latest, by Bloom Paul D, was filed 2026-09-03.
Read the full summary
In the 180 days to 2026-10-28, Gevo insiders were net sellers of GEVO, a net $1.6M across purchases and sales reported on Form 4 by 2 buyers and 7 sellers. Sales outweighed purchases more than tenfold by value. 2 different insiders reported purchases within the last 90 days, a cluster buy, which is rarer than a single purchase. 14% of the 21 insider sales were made under a Rule 10b5-1 plan; the rest were not flagged as planned. Insiders filed 10 Form 144 notices of intent to sell in the 90 days to 2026-10-28, covering $552.3K of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.